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doi:10.1016/j.jtcvs.2006.09.062bjective: Lung transplantation has been increasingly applied to patients over the
ge of 60 years. Importantly, the procedure of choice, single versus bilateral lung
ransplantation, remains unclear. Therefore, the purpose of this study was to exam-
ne short- and midterm outcomes in this age group with particular attention to
rocedure type.
ethods: All first lung transplant recipients, 60 years of age or older, reported to the
nited Network for Organ Sharing from 1998 to 2004 were divided into two groups:
ilateral and single lung transplantation. A retrospective review of pertinent baseline
haracteristics, clinical parameters, and outcomes was performed. Kaplan–Meier
ethodology was used to estimate and Cox proportional hazards regression mod-
ling was used to compare posttransplant survival between these groups. Addition-
lly, propensity scores analysis was performed.
esults: During the study period, 1656 lung transplant recipients were 60 years of
ge or older (mean 62.7  2.4 years, median 62 years). Of these, 364 (28%) had
ilateral and 1292 (78%) had single lung transplantation. Survival was not statisti-
ally different between the two groups. In the multivariate analysis, bilateral versus
ingle lung transplantation was not a predictor of mortality. Idiopathic pulmonary
brosis and a donor tobacco history of more than 20 pack-years were significantly
ssociated with mortality (P  .003, CI 1.12–1.76; and P  .006, CI 1.09–1.63;
espectively).
onclusions: The survival of lung transplant recipients 60 years of age or older who
nderwent bilateral versus single lung transplantation is comparable. These data
uggest that type of procedure is not a predictor of mortality in this age group.
diopathic pulmonary fibrosis and donor cigarette use of more than 20 pack-years
ere independently associated with mortality.
esults of clinical lung transplantation (LTx) over the past two decades have
progressively improved. Nonetheless, LTx is limited by the availability of
donor organs, and a careful selection of LTx recipients is critically impor-
ant. The International Society for Heart and Lung Transplantation (ISHLT) guide-
ines for selection of appropriate candidates for LTx have suggested an age limit of
0 years for bilateral (BLT) and 65 years for single (SLT) lung transplantatio1 The
ge limitation was based on previous reports showing that older patients have
ignificantly higher mortality than younger patients.2 However, the age distinctio
or BLT versus SLT has not been clearly supported by the literature. The few reports
hat address this issue have been limited to disease-specific database analyses 3,4 and
 single-center report with a small number of patients.5
As the number of older patients listed for LTx increases, the procedure of choice
BLT vs SLT) for these patients requires further scrutiny. We therefore analyzed the
mpact of procedure type on short- and midterm survival in recipients 60 years of age
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5
TXr older for all disease types, using data reported to the 
etwork for Organ Sharing (UNOS) registry in the recen
etween 1998 and 2004.
aterials and Methods
atient Population
ata reported to the UNOS registry for LTx performed bet
anuary 1, 1998 and December 31, 2004 were analyzed. The
ow-up period was up to September 2005, which is when th
ere created. This time period was chosen to represent a m
ohort of patients in light of advancements made in LTx. Amo
785 first-time LTx recipients, we identified 1656 patients 60 ye
ge or older, and these were stratified by type of transplant proc
LT (n  364) and SLT (n  1292). The patient characteristics a
hown in Table 1.
tatistical Analyses and Survival
ll available data from the UNOS Standard Transplant Analysis and
esearch (STAR) files were imported into Stata version 9.0 (Stata-
orp. College Station, Tex), which was used for statistical computa-
ions. Continuous variables are summarized as mean  standard
eviation. Bivariate comparison of continuous variables was per-
Abbreviations and Acronyms
BLT  bilateral lung transplantation
COPD  chronic obstructive pulmonary disease
FVC  forced vital capacity
IPF  idiopathic pulmonary fibrosis
ISHLT International Society for Heart and Lung
Transplantation
LTx  lung transplantation
SLT  single lung transplantation
STAR  Standard Transplant Analysis and Research
(files)
UNOS  United Network for Organ Sharing
ABLE 1. Clinical characteristics by type of procedure
linical characteristics BLT (N  364) No. with d
ge (y) 62.3 2.1 364
emale gender 134 (37%) 364
onor age (y) 32.1 14.4 364
ative disease 364
COPD 224 (62%)
IPF 80 (22%)
Others 60 (16%)
MI 24.1  3.9 356
EV1 (%) 35.5 23.4
VC (%) 55.5 17.9 340
ean PAP (mm Hg) 26.2 8.1 281
schemia time (h) 5.3 1.6 322
ollow-up time (mo) 21 19 364
LT, Bilateral lung transplantation; SLT, single lung transplantation; COPD,
ody mass index; FEV1 (%), forced expiratory volume (percent predicted); FVC,
42 The Journal of Thoracic and Cardiovascular Surgery ● Febrd
,
-
s
e
f
e:
ormed with a Student t test. Associations between categorical vari-
bles were tested by the Pearson 2 test. Survival estimates for each
rocedure type were calculated by the Kaplan–Meier method, and
tatistical differences between survival curves were assessed by the
og–rank (Mantel–Cox) test. Multivariate analyses were performed by
ox proportional hazards regression to determine whether type of
rocedure was an independent predictor of mortality after adjustment
or potential cofounders. During the analyses for model selection,
nly variables with more than two thirds of available data were
onsidered, and these are listed in Table 2. To more accu
stimate confidence intervals, we made the assumption that the miss-
ng data were missing at random and performed imputation of missing
ata using the single regression method. Our findings proved to be
obust across models that included both imputed and nonimputed (ie,
ase-wise deletion of observations with missing data points) data. We
herefore chose to construct a model that reflects the effect of the
linically relevant potential cofounders listed in Table 2. This m
lso has the lowest Akaike and Schwarz Bayesian information crite-
ion scores, which makes it a model of choice.
In addition to the standard multivariate analysis, to reduce bias and
ncrease precision, we generated propensity scores by developing a
odel that estimates the probability of a patient receiving BLT versus
LT. The factors used in this model were recipient age, donor age,
ody mass index, pulmonary artery mean pressure, forced vital ca-
acity (FVC) (percent predicted), and year of transplant. Propensity
cores were analyzed by the regression adjustment technique; that is,
oth the propensity scores and type of procedure (“treatment factor”)
ere included in a Cox regression model.
esults
atient Characteristics
f the 1656 first LTx recipients, 364 patients received BLT
nd 1292 had SLT. Their ages ranged from 60 to 87 years old
mean 62.7 2.4 years, median 62 years). The age distribution
s shown in Figure 1. Eighty-eight percent of the patients
etween 60 and 65 years old. Interestingly, there were 196
atients (12%) above the age of 65 years. Furthermore, from
SLT (N  1292) No. with data P value
62.8 2.5 1292 .002
553 (43%) 1292 .004
32.8 13.8 1291 .4
1292 .001
863 (67%)
349 (27%)
80 (6%)
25.2 6.2 1220 .001
34.5 20.6 .66
53.1 16.3 1162 .025
24.7 8.5 1002 .01
3.78 1.3 1107 .001
26 21 1291 .001
ic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; BMI,ata
chron
forced vital capacity; PAP, pulmonary artery pressure.
uary 2007
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TX998 to 2004, there was an increase from 19% to 27% in the
umber of first LTx recipients 60 years of age and older.
ikewise, the number of BLTs performed among these pa-
ients increased from 14% in 1998 to 34% in 2004 (Figu
able 1 compares the details of patient preoperative cli
haracteristics between the two groups. Patients who received
LT versus SLT were statistically younger (62.3  2.1 years
s 62.8  2.5 years; P  .002. There were fewer female
atients in the BLT group (37% vs 43%; P .04), lower body
ass index (24.1  3.9 vs 25.2  6.2; P  .001), higher
ercent predicted FVC (55.5%  17.9% vs 53.1%  16.3%;
 .025), and mean pulmonary artery pressure (26.2  8.1
m Hg vs 24.7 8.5 mm Hg; P .01). Graft ischemia time,
ecorded as the time from recovery to implantation of the
econd lung in BLT, was longer in the BLT group (5.3  1.6
ours vs 3.8  1.3 hours; P  .001). Furthermore, the BLT
roup had shorter mean follow-up time than the SLT group (21
19 months vs 26  21 months; P  .001).
atient Survival
s shown in Figure 3, 30-day survival was 94.9% for BL
5.2% for SLT and 1-year survival was also comparable: 78%
or BLT and 77.2% for SLT. Although there appeared to be a
avorable survival trend with BLT (45.3% vs 38% for SLT) at
years, there was no statistically significant difference in the
ABLE 2. Multivariate Cox proportional hazards model*
isk factor HR P value 95% CI
LT vs SLT 0.989 .94 0.76 1.28
ge (y) 1.001 .98 0.96 1.03
ender (F vs M) 0.885 .23 0.72 1.08
PF (vs other native diseases) 1.405 .003 1.12 1.76
MI (kg/m2) 0.991 .45 .97 1.01
onor age (y) 1.004 .29 .99 1.01
onor  20 pack-year
cigarette use
1.333 .006 1.09 1.63
LA mismatch level 1.066 .44 0.91 1.26
(HLA  4 vs HLA  5.6)
ransplant year 0.996 .89 .94 1.06
schemia time (h) 0.949 .15 .88 1.02
R, Hazard ratio; CL, confidence limits; BLT, bilateral lung transplantation;
LT, single lung transplantation; IPF, idiopathic pulmonary fibrosis; BMI,
ody mass index. *Other risk factors at the time of transplant that were
onsidered for the multivariate analyses include recipient factors: type of
ative disease, on ventilator, on life support (intra-aortic balloon pumping,
xtracorporeal membrane oxygenation), history of hypertension, history of
iabetes, forced vital capacity (percent predicted), forced expiratory vol-
me in 1 second (percent predicted), most recent pulmonary artery mean
ressure, most recent panel-reactive antibody (percent) at transplant,
ransfusions from registration to transplant, serum creatinine, total biliru-
in, and cytomegalovirus status. Other donor factors include donor cyto-
egalovirus status and deceased donor antihypertensive use within 24
ours before crossclamp. Recipient/donor gender and cytomegalovirus
ismatch were also considered.verall survival experiences between these groups (P  .33). a
The Journal of Thoracic).
d
ikewise, no statistical survival advantage of either procedure
ype was noted when patients were further analyzed by diag-
osis. For patients with chronic obstructive pulmonary disease
COPD), 1-, 3-, and 5-year survivals were 81.2%, 62.9%, and
0.7% for BLT and 81.5%, 61.5%, and 42.5% for SLT, re-
pectively (P  .56) (Figure 4). Similarly, patients who 
eived LTx for idiopathic pulmonary fibrosis (IPF) had 1-, 3-,
nd 5-year survivals of 72.4%, 54.3%, and 54.3% for BLT and
9.4%, 51.7%, and 33.1% for SLT, respectively (P  .51)
Figure 5). Independent of procedure type, 30-day mort
as less than 7% for IPF, COPD, and the entire cohort.
dditionally, when only patients who are 61 years of age or
lder are considered in all the above survival analyses (P .39
or the entire cohort), the results are similar.
ultivariate Analysis of Patient Survival
n a multivariate Cox proportional hazards model that was ad-
usted for recipient age, gender, body mass index, and native
isease and for donor age, cigarette use, transplant year, and HLA
ismatch; IPF and donor cigarette use for more than 20 pack-
ears emerged as significant predictors of mortality. Type of
rocedure was not a significant predictor of mortality (Tabl
ther variables that were considered for the model were not
tatistically significant and are shown in the appendix to Ta
Furthermore, propensity scores analysis by the regression
djustment technique was performed, whereby both the pro-
ensity scores and type of procedure, as well as other potential
isk factors, were included as predictors of outcome. BLT
ersus SLT still did not emerge as predictors of mortality,
hereas donor cigarette use for more than 20 pack-years and
PF remained independent predictors.
iscussion
his study of a large cohort of elderly patients (60 years of age
Figure 1. Age distribution.nd older) who received LTx from 1998 to 2004 did not show
and Cardiovascular Surgery ● Volume 133, Number 2 543
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5
TXignificant differences in short- and midterm survival between
LT and SLT. In addition, IPF and heavy donor tobacco use
ere independently associated with mortality. Moreover, op-
rative mortality was less than 10%, which is better than
revious reports.
Steady improvements in the management of LTx patients
ave led to better outcomes. This has emboldened programs to
ffer LTx to older patients. The ISHLT/UNOS registry has
hown a steady increase in the proportion of LTx recipients 60
ears of age and older.6 This raises the important and pers-
ently controversial question of which procedure type (BLT vs
LT) is optimal in patients over the age of 60. Meyer and
ssociates3 analyzed the ISHLT/UNOS registry for all rec-
nts who received LTx for COPD between 1991 and 1997.
hey concluded that SLT offered acceptable early survival, but
ong-term survival data favored BLT except in patients over
he age of 60. Likewise, a single-center study of 126 LTx
ecipients from 1991 to 1996 demonstrated survival advan-
ages of BLT over SLT in patients with COPD, but increased
orbidity in BLT patients over the age of 55 years. The
uthors therefore discouraged the use of BLT in patients above
his age.7 A more recent analysis of 1994-2000 UNOS data
atients with IPF found no difference in survival between SLT
nd BLT in the subanalysis of patients 60 to 69 years o4
Nonetheless, we hypothesized that modern improvements
n LTx have led to better outcomes in elderly patients. Our
nalysis of first LTx recipients 60 years of age or older re-
orted to UNOS from 1998 to 2004 showed that procedure
ype was not a predictor of mortality by unadjusted or adjusted
nalysis. In contrast to older studies, survival was markedly
etter in this study. According to the report by Meyer and
olleagues,3 patients older than 60 years with COPD 
eceived LTx between 1991 and 1997 had 30-day and 1-year
urvivals of 93.5% and 72.9%, respectively, for SLT versus
7.8% and 66%, respectively, for BLT. In our study, 30-day
urvival was about 95% for both the BLT and SLT groups and
-year survival was 77.2% for SLT and 78% for BLT for the
igure 2. Distribution of type of procedure. BLT, Bilateral lung
ransplantation; SLT, single lung transplantation.ntire cohort. Furthermore, when only patients with COPD are c
44 The Journal of Thoracic and Cardiovascular Surgery ● Febre.
nalyzed, the 30-day and 1-year survivals are 95.8% and
1.5% respectively, for SLT and 95% and 81.2%, respectively,
or BLT. This suggests that concerns over increased perioper-
tive mortality for BLT owing to a more complex operation are
nfounded in the recent cohort. The favorable survival trend
bserved by 5 years with BLT did not achieve statistical
ignificance in our study. However, since we chose a recent
ime period, the number of patients who could be analyzed at
years was small. The 5-year survival of 45% for BLT and
9% for SLT for this cohort of elderly patients is lower than
he 49% overall 5-year survival for LTx reported by the 2005
SHLT registry.6
The multivariate analysis identified IPF and donor cigarette
se of more than 20 pack-years as independent predictors of
ortality. Donor tobacco use has been previously reported in
he ISHLT data set as a risk factor for long-term mortality, but
t is interesting that IPF remains a risk in the elderly cohort.
lthough this study does not allow further exploration of this
henomenon, it suggests that one should exercise caution when
sing a donor with more than 20 pack-years of cigarette use in
lderly patients with IPF.
The decision to perform BLT or SLT in elderly patients is
omewhat entrenched in institutions. Although, guidelines ex-
st with age cutoffs (BLT in patients 60 and SLT in patients
65), several centers perform BLT in all patients preferen-
ially. Overall, proponents of SLT in LTx have argued that
LT is an easier procedure to perform, has less morbidity and
ortality associated with it than BLT, and results in less
schemic time; therefore, an SLT has better early graft func-
ion, has improved early survival, and will allow more patients
o receive LTx. Proponents of BLT have argued that BLTs
esult in fewer ventilation/perfusion mismatches, are easier to
igure 3. Kaplan–Meier estimates of survival for all patients,
tratified by type of procedure. BLT, Bilateral lung transplanta-
ion; SLT, single lung transplantation.are for in the perioperative period, will provide better overall
uary 2007
Nwakanma et al Cardiothoracic TransplantationFigure 4. Kaplan–Meier estimates of survival for patients with chronic obstructive pulmonary disease, stratified by
type of procedure. BLT, Bilateral lung transplantation; SLT, single lung transplantation.TXFigure 5. Kaplan–Meier estimates of survival for patients with idiopathic pulmonary fibrosis, stratified by type of
procedure. BLT, Bilateral lung transplantation; SLT, single lung transplantation.The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 2 545
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5
TXung function, are protective against the physiologic manifes-
ations of obliterative bronchiolitis, and offer a better long-term
urvival.8 Furthermore, although BLT does entail longer do
schemic times for the second lung implanted, this has not
ranslated into measurable adverse sequelae.9,10
Both procedures have been accepted by practitioners and likely
ill be acceptable for the foreseeable future, and the percentage of
LTs performed in elderly patients has been increasing. Our
urrent report refutes the concerns about higher perioperative
ortality for BLT in this patient population, and although a
tatistical survival advantage was not demonstrated, other single-
enter reports suggest that BLT is overall associated with better
ong-term survival and freedom from bronchiolitis obliteran11
ur findings also agree with a recently published report of 107
onsecutive LTx recipients 61 years of age and older that dem-
nstrated comparable short- and midterm outcomes achieved with
LT and SLT.12 In their study, Palmer and associates12 also
eported 1-, 2-, and 5-year survival estimates of 82%, 75%, and
8%, respectively, for BLT and 78%, 70%, and 44%, respec-
ively, for SLT. The survival advantage of BLT also did not
chieve statistical significance. Even if use of BLT for the elderly
opulation has a positive impact on patient survival, concerns
emain about whether this strategy may decrease the availability
f donor organs.
Our institution prefers the use of BLT for all patients because
e believe that there are short- and long-term advantages. How-
ver, owing to the limited number of organs available, we recog-
ize that SLT is a reasonable option for older patients with COPD
nd IPF as compared with the alternative, which is death. In
eneral, it appears that BLT has already been empirically accepted
y many in the transplant community inasmuch as the percentage
f patients over 60 receiving BLT continuously increased between
998 and 2004. Ultimately, more studies and the analysis of
ong-term results from this database will be necessary to deter-
ine an advantage of one procedure type over another.
The current study has the inherent limitations of the review of
multi-institutional voluntary registry. Analysis of survival data
ay be compromised by lack of uniformity of reporting and
onstandardized organ preservation and surgical techniques, as
ell as postoperative and immunosuppressive management. Only
rst LTx recipients were included to help achieve a more uniform
ohort of patients. The 1998 to 2004 era was also selected to
eflect the advancements that have recently evolved in LTx. There
ay have been selection bias in favor of BLT because our data did
how that the BLT patients were statistically younger. The clinical
ignificance of 6 months’ difference is, however, questionable.
his difference is most likely a reflection of the tendency to
erform transplantation in patients who are relatively younger and
o use BLT. However, age is one of the clinical cofounders that
as controlled for in the Cox proportional hazards model. There
ere fewer female recipients, lower body mass index, and higher
ercent predicted FVC in the BLT group, although these patients
lso had higher mean pulmonary artery pressure. On the other
46 The Journal of Thoracic and Cardiovascular Surgery ● Febrand, the differences in these parameters between the two groups
o not appear to have significant clinical implications. When these
arameters are controlled for in a multivariate model as well as
ropensity scores analysis, the same results were obtained. Eval-
ation of other secondary end points such as bronchiolitis oblit-
rans may also provide important insights into the advantage of
ne procedure over another.
onclusions
ur analysis of the UNOS database from a recent era showed
omparable short- and midterm survival for BLT versus SLT in
atients 60 years of age or older. These data suggest that recipients
lder than 60 years should not be excluded from the use of BLT
ased on concerns of higher early mortality. Long-term outcomes
ill better define any survival advantage of BLT over SLT, and
uture studies will help to determine the best use of BLT versus
LT in the older population.
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TXiscussion
r G. Alexander Patterson (St Louis, Mo). This study was under-
aken primarily to determine whether there was any difference in
utcome between SLT and BLT recipients of older age. The authors
ave noted the expected preoperative differences between BLT and
LT recipients with respect to age, preoperative FVC, and pulmonary
rtery pressure, all of which you would expect to be different, but I
ould argue those differences are clinically irrelevant.
There are a number of observations in this report that I think are
mportant. First, perioperative mortality was surprisingly low in this
ge group. Our own experience at Washington University is similar,
ctually. Among 168 patients over the age of 60, our operative
ortality rate was only 2.4%. I think low mortality rates are achiev-
ble in these patients. Mortality did not differ between SLT and BLT
ecipients. One-year and 5-year survivals are similar for both of these
rocedures in older patients but lower than we would expect and
ower than previously has been reported for younger recipients. In
ddition, the study provides important confirmation of previously
eported data suggesting poorer outcome with older donors and do-
ors with a significant smoking history. I know we are going to be
alking about that in a subsequent presentation. However, there are
ome limitations in this study that I think are relevant. First of all, it
oes suffer from the defects of a multicenter, multiprotocol registry
ith limited data fields. Dr Nwakanma, you did acknowledge that in
our slides, but I think of more importance is that this information was
ccumulated in an era predating the current allocation scheme, which
llocates priority for donor lungs by severity of disease rather than by
aiting time. The former system of priority by waiting time favored
he patients with emphysema on the waiting list. The current system
f priority by severity of disease favors the patients with fibrosis. As
ou might expect, 65% of the recipients reported from this previous
ra in the current report had emphysema and only 26% had fibrosis.
e should be very careful in extrapolating these results in elderly
atients to the current era. It is likely that in future years older patients
ith fibrosis will predominate on our waiting list. The authors have
learly demonstrated what is already known, that patients with fibrosis
ave poorer immediate and long-term outcome than patients with
bstructive lung disease after LTx.
I have two questions. Dr Nwakanma, could you comment on
hat you think the current algorithm or the current lung allocation
coring system might do to these results looking forward? Also, I
hink it would be helpful if you could tell us where that 87-year-old
atient received the LTx, because I think the program directors of
hat program need psychiatric help.
Dr Nwakanma. Thank you, Dr. Patterson, for your time and
or commenting on our paper.
To answer your first question, as you mentioned, the new lung
llocation system actually bases on severity of disease. We believe that
hat we have been able to show with these data is that the patients who
re older than 60 do not have a worse outcome with BLT in a recent
ohort. Therefore, if the organ is available and the elderly patient has a
igh lung allocation system score, then the patient should not be deprived
f receiving bilateral lungs. The new system was only implemented in, I
elieve, the spring of 2005, so time will tell the actual effect of the new
llocation system on the choice of SLT versus BLT in elderly patients.
As regards your second question, we had the same question in
ur minds when we saw that there was an 87-year-old patient. We
riple-checked by the transplant identification and by the donor f
The Journal of Thoracicdentification, and we contacted UNOS several times. They con-
rmed verbally and in writing that there was an 87-year-old
ecipient according to their data. Whether that was a mistake or
ot, they could not clarify, but they told us it was an actual
ecipient, and the patient actually received the LTx in July 1998,
ut the location of the program where the transplantation was
erformed is confidential information, as you might imagine. It
as not done at Johns Hopkins.
Dr Thomas C. Wozniak (Indianapolis, Ind). I like this trial because
t shows that the mortality really is not any different for BLT. Like
robably most programs, we are listing more and more people over the
ge of 60. In the past we had traditionally favored SLT in those patients
f they could tolerate that. However, what we are beginning to see now are
ore patients whom we really wish we had treated with BLT rather than
LT. They have survived, but I do not believe they have recovered and
eached a functional quality of life that they could have, and they have
truggled. Do you have any way to look at the functional outcome as
pposed to the actual survival in these patients?
Dr Nwakanma. Thank you for your question. That’s a nice
omment. We really wish we could, but the data do not provide
eliable information to make a good conclusion in terms of func-
ional outcomes.
Dr Robert Shen (Charlottesville, Va). I was quite interested by the
ndings of your multivariate analysis, which showed that the only two
actors that were predictive of increased mortality were smoking greater
han 20 years in the donor and the diagnosis of IPF. The most recent
nnual report of the ISHLT data shows that body mass index
nd advanced age of the recipient were the only two factors in
hat registry that were predictive of increased mortality. Do you
ave a hypothesis or an explanation for the difference in the two
utcomes based on the two different registries?
Dr Nwakanma. Thank you for your questions. The 2005
SHLT registry report by Trulock and colleagues was looking at
atients mainly from 1994 to 2003. Our patient cohort includes
atients from 1998 to 2004, and, as I mentioned, we chose this
eriod to represent mainly the modern cohort and reflect the
odern improvements in LTx. It is possible that a difference in the
redictors of mortality is based on the different time era. More-
ver, the registry report looks at all patients, but our analysis
ooked at only those who are older than 60 years. Those differ-
nces might explain the different results.
Dr Bryan F. Meyers (St Louis, Mo). I am interested in your results
ith regard to IPF and the absence of an effect of SLT versus BLT in
hese older patients. Your results are particularly interesting in light of the
act that Meyer and colleagues, last year, came to an opposite conclu-
ion—that older patients did worse with the BLT for fibrosis than with
LT—and I think it was probably based on much the same data. I
ondered if you are aware of that report and if you have any estimate
f why the two reports come to different conclusions.
Dr Nwakanma. Thank you for that question. The answer also lies
n the answers I gave for the previous question. The report from
eyer and colleagues, reported in 2005, was looking, again, at all
atients regardless of age who had native disease of IPF. However,
hen they did a subanalysis that looked at only patients who were 60
o 69 years old, they actually found no difference between SLT and
LT in that subgroup of patients according to that particular paper.
lthough we have about the same time period, they actually alsoound no difference for the subgroup between 60 to 69 years old.
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